Return to Perspectives
COVID-19 Legal Resource Guide
June 22, 2020

In Response to NAD Inquiry, Provezza Health Discontinues COVID-19 Claims for Elderberry Syrup

As part of its routine monitoring program, NAD challenged an Instagram post by Provezza Health, LLC, which advertised its Provezza Elderberry Syrup. NAD inquired whether the statements “Potent Immune Support During A Severe Season” and “Provezza is highly concentrated to deliver antioxidant action for immune defense,” conveyed the implied claim that the product protects users against COVID-19. While Provezza did not believe its post made the COVID-19-related implied claim, it agreed to discontinue the post and committed to refraining from making express or implied COVID-19 treatment claims in the future.

Authors and Editors

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.